SURF | Surface Oncology Inc
Category: Consumer goods
Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 66.64M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: March 9, 2023
Earnings History Date EPS / Forecast Revenue / Forecast May 10, 2023 March 9, 2023 -0.35 / -0.3217- / 3.85MNovember 15, 2022 - / -0.4683- / 100KNovember 2, 2022 -0.39 / -0.4567- / 100KAugust 3, 2022 -0.46 / -0.4483- / -view more
Historical Data Date Price Open High Low Vol Change ER Aug 11, 2022 1.850 1.850 2.090
1.800
3.57M 2.21% Aug 10, 2022 1.810 1.740 1.850
1.680
580.46K 6.47% Aug 9, 2022 1.700 1.770 1.770
1.700
502.85K -5.56% Aug 8, 2022 1.800 1.790 1.820
1.770
696.72K 1.12% Aug 5, 2022 1.780 1.750 1.830
1.735
859.43K -1.11% Aug 4, 2022 1.800 1.800 1.830
1.760
598.66K 3.45% Aug 3, 2022 1.740 1.700 1.820
1.695
922.62K 4.82% Aug 2, 2022 1.660 1.640 1.700
1.610
349.51K 1.22% Aug 1, 2022 1.640 1.710 1.710
1.630
428.00K -4.09% Jul 29, 2022 1.710 1.700 1.710
1.660
357.38K 0% view more
SURF
News
Surface Oncology, Roche Team Up to Develop SRF388 Combo Therapy for Liver Cancer finance.yahoo.com Jul 9, 2022 10:04 am
Perrigo (PRGO) Beats Q4 Earnings and Revenue Estimates finance.yahoo.com Jul 9, 2022 8:55 am
Health Check: How Prudently Does Surface Oncology (NASDAQ:SURF) Use Debt? finance.yahoo.com Jul 9, 2022 8:50 am
The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut finance.yahoo.com Jul 9, 2022 8:10 am
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2021 finance.yahoo.com Jul 9, 2022 7:10 am
Surface Oncology to Collaborate with Merck on Immuno-Oncology Study Evaluating SRF388, Targeting IL-27, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors finance.yahoo.com Jul 9, 2022 7:00 am
Surface Oncology to Collaborate with Roche on Immuno-Oncology Study Evaluating SRF388, Targeting IL-27, as Part of a Novel Combination in Patients with Advanced Treatment-naïve Hepatocellular Carcinoma finance.yahoo.com Jul 9, 2022 7:00 am
3 Top Biotech Stocks to Watch in November fool.com Jul 9, 2022 6:57 am
If You Had Bought Surface Oncology (NASDAQ:SURF) Stock A Year Ago, You Could Pocket A 498% Gain Today finance.yahoo.com Jul 9, 2022 4:37 am
Strong week for Surface Oncology (NASDAQ:SURF) shareholders doesn't alleviate pain of one-year loss finance.yahoo.com Jul 7, 2022 8:00 am
Surface Oncology to Participate in Upcoming Investor Conferences finance.yahoo.com Jun 1, 2022 8:00 am
Surface Oncology to Participate in Upcoming Investor Conferences finance.yahoo.com May 17, 2022 4:30 pm Surface Oncology gains after Q1 updates; cash runway extends to 2024 seekingalpha.com May 9, 2022 9:11 pm Surface Oncology GAAP EPS of $0.13 beats by $0.38, revenue of $30M beats by $17.42M seekingalpha.com May 9, 2022 7:38 pm
Surface Oncology Named one of the 2022 Best Places to Work by Boston Business Journal finance.yahoo.com Apr 21, 2022 4:05 pm Surface Oncology begins phase 2 trials of SRF388 in liver, lung cancers seekingalpha.com Apr 14, 2022 9:28 pm
Surface Oncology Highlights New SRF388 Data At AACR Meeting finance.yahoo.com Apr 11, 2022 9:47 am
Do Institutions Own Surface Oncology, Inc. (NASDAQ:SURF) Shares? finance.yahoo.com Feb 24, 2022 7:55 am
Surface Oncology Named a 2021 Top Place to Work by the Boston Globe finance.yahoo.com Dec 3, 2021 7:00 am
Surface Oncology Appoints Denice Torres to Board of Directors finance.yahoo.com Jul 9, 2022 7:00 am This company doesn't provide a dividend.
Key Persons Chairman : Chairperson: Daniel Lynch Talk about Surface Oncology Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
investors.surfaceoncology.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis